Journal DOI 10.68956/journal.human-performance-futures

Creative Commons source reading · Participation and athlete pathways

Risk Stratification, Exercise Prescription, and Sport Participation in Individuals with Aortic Valve Disease

Francesco Perone; Edoardo Conte; Stefano Palermi; Geza Halasz; Marco Ambrosetti; Luigi Sciarra; Giacomo Frati; Mariangela Peruzzi; Elena Cavarretta; Annachiara Pingitore

Originally published in J Cardiovasc Dev Dis · 2026-10-03

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Aortic valve disease (AVD), including bicuspid aortic valve (BAV) and aortic regurgitation (AR), presents a complex challenge in sports cardiology. Balancing the cardiovascular benefits of physical activity with the hemodynamic risks associated with valvular dysfunction and aortopathy requires precise risk stratification. The present review comprehensively analyses the contemporary criteria for exercise prescription and competitive sports participation in individuals with AVD, highlighting also the distinctions between the European guidelines (European Society of Cardiology—ESC), the Italian Sports Cardiology Guidelines for competitive sport practice (COCIS 2023) and the recommendations for exercise prescription in cardiovascular diseases promoted by the Italian Sports Cardiology Society (SIC Sport) and the Italian Federation for…

6. Discussion and Future Perspectives

The intersection of aortic valve disease (AVD), associated aortopathies, and sports cardiology is undergoing a profound paradigm shift. Historically, the theoretical fear of exercise-induced adverse events—such as accelerated valvular deterioration or acute aortic dissection—led to highly restrictive recommendations [32]. However, a modern clinical perspective seeks to prevent a sedentary lifestyle, which remains a primary modifiable cardiovascular risk factor. Consequently, the contemporary clinical focus has evolved from blanket prohibition to exploring how exercise can be safely prescribed to maximize cardiometabolic health in these patients [4]. Although European and North American recommendations are broadly concordant, the 2025 AHA/ACC guidance suggests a more permissive shared decision-making scheme in selected clinical…

7. Conclusions

Prescribing exercise for patients with aortic valve disease requires balancing cardiometabolic benefits against potential hemodynamic risks. Contemporary sports cardiology has shifted from absolute restrictions toward individualized prescriptions. Current guidelines agree that asymptomatic individuals with mild-to-moderate AVD, preserved ventricular function, and normal aortic dimensions can safely engage in competitive sports. Conversely, severe valvulopathy, LV dysfunction, or significant aortopathy necessitates sports restriction and surgical evaluation. Nevertheless, rigorous imaging surveillance, exercise stress testing, and shared decision-making are essential to safely optimize athletic participation in this population.

Editorial reading guide

  • Whose development is represented, and who may be excluded by the sampling or pathway?
  • Which outcome reflects durable learning or development rather than short-term selection?